Clinical Trial Update: A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers [Phase 1]

View source ↗

Summary

Phase I trial assessing safety and immunogenicity of the MVA85A TB vaccine in healthy Gambian volunteers has been completed. The study evaluated safety and immu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• MVA85A (Modified Vaccinia Ankara expressing antigen 85A)

Snippet

Sponsor: University of Oxford | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED